Telemonitoring for Better Glycemic Control in Tunisian Adults with Diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with diabetes and HbA1c between 7% and 10% will be assigned to either a telemonitoring program using a dedicated mobile app and web platform or to usual care. The study will compare changes in HbA1c and blood glucose levels to see if remote management helps achieve better glycemic control. Eligible individuals must have stable diabetes treatment for at least four weeks and not have certain conditions that could interfere with participation. The trial is conducted at University Hospital Fattouma Bourguiba Monastir under the leadership of the University of Monastir.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of diabetes mellitus with HbA1c between 7% and 10%.
* Stable antidiabetic treatment for at least 4 weeks prior to enrollment.

Exclusion Criteria:

* Serum creatinine \>200 µmol/L.
* Acute coronary syndrome or stroke.
* Dementia.
* Pregnancy.
* Inability to participate in or comply with the telemonitoring intervention.
* Severe diabetic retinopathy.

Where it's running

• University Hospital Fattouma Bourguiba Monastir
  Monastir, Tunisia Recruiting

Study contacts

• Study coordinator: Nouira Semir
• Email: semir.nouira@rns.tn
• Phone: 0021673106046

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Reset-INSPIRE: See if CGM can reveal insulin sensitivity in people at risk for MASLD

  This study tests whether real-time CGM data can accurately reflect insulin sensitivity in adults without diabetes who are at risk for MASLD.

  Recruiting National University Health System, Singapore · Singapore, Singapore · NCT07861191

• Rapid guideline-based therapy after a heart attack

  This project tests whether starting guideline-driven secondary prevention soon after a heart attack helps people who had PCI reach better risk-factor control and fewer heart events.

  Recruiting Zuyderland Medisch Centrum · Heerlen, Limburg · NCT07773272

• Continuous Vital Sign Monitoring in a Gastro-surgical Ward

  This study tests whether wearing sensors that continuously track vital signs helps detect deterioration earlier for adults on a gastro-surgical ward, in addition to standard NEWS-2 monitoring.

  Recruiting University Hospital, Akershus · Lørenskog, Akershus · NCT07690267

• Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases

  This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.

  Recruiting University of Calgary · Calgary, Alberta · NCT07609381

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.